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Objectfves: To test he hypothesis that endothelial ceil damage and hypoxia re related to the activity of neutrophil e astase 
in patients with peripheral therosclerosis. 
Design" A cross-sectional serological study in a tertiary referral, University Hospital. 
Materials" Venous blood was obtained from 22 patients with peripheral vascular disease and an equal number of age and 
sex matched controls. 
Methods: Neutrophil elastase and two markers of endothelial ceil damage (von Willebrand factor and soluble 
thrombomodulin) were measured inplasma by ELISA. Hypoxia was measured by percutaneous oxygen (by oximeter) atthe 
dorsum of the foot. 
Results: Patients had higher von Willebrand factor, higher soluble thrombomodulin a d higher elastase but lower 
percutaneous oxygen (all p < 0.001). In the patient's group, there were significant inverse correlates between von 
Willebrand factor and percutaneous oxygen (p = 0.004) and between soluble thrombomodulin and percutaneous oxygen 
(p = 0.011) while elastase correlated positively with soluble thrombomodulin (p -- 0.023). 
Conclusions: Our data support the hypothesis that release of elastase from activated neutrophils relates to endothelial cell 
damage. This may contribute to hypoxia nd may result in the deterioration i  clinically assessed atherosclerosis. 
Key Words: von Willebrand factor; Soluble thrombomodulin; Percutaneous oxygen; NeutrophiI elastase; Hypoxia; 
Atherosclerosis. 
Introduction 
Limb ischaemia, resulting from the inadequate perfu- 
sion of the peripheral circulation, is an important and 
possibly fatal consequence of atherosclerosis. 1-3 Inter- 
mittent claudication is, however, the commonest 
symptom in patients with peripheral atherosclerosis 
with a prevalence of1-1.5% below the age of 50, rising 
to 4-6% in older patients. 4 It is associated with a high 
mortality rate with a two-fold increased risk of death 
and a decrease in life expectancy often years, and is an 
independent risk factor for myocardial infarction and 
thrombotic events. 5-7 Claudication may therefore 
place an additional burden on the arteriopath and 
some have advocated early surgical intervention. 8 
The precise aetiology of intermittent claudication is
unknown but is likely to include damage to the 
endothelium and there may also be a role for 
*Please address all correspondence to: Dr Andrew Blann. 
microthrombi. 9 Markers of endothelial cell damage 
include von Willebrand factor and soluble thrombo- 
modulin, and levels of both these molecules are raised 
in atherosclerosis, l°'n The causes of the endothelial 
cell damage are unclear but may involve the cytotoxic 
products of activated polymorphonuclear leukocytes, 
uch as the proteolytic enzyme lastase. 9'12 Changes in 
blood rheology and the risk factors for atherosclerosis 
may also be responsible for vascular injury and these 
may be cause the trapping and subsequent activation 
of leukocytes. 1°'13"14 Hypoxia, resulting from athero- 
sclerosis of the arteries upplying the leg, may result 
in a vicious spiral of activated neutrophils, thrombus 
formation, decreasing blood flow and increasing 
hypoxia. There may also be a degree of autodestruc- 
tion as a damaged endothelium ay promote throm- 
bus formation via the release of von Willebrand factor, 
and hypoxia can increase the adhesion of poly- 
morphonuclear leukocytes to the endothelium and 
induce endothelial cell injury directly. 93°'15"16 Fur- 
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thermore, in bovine microvascular nd macrovascular 
endothelial cells, thrombomodulin activity and anti- 
gen are reduced by hypoxia, which may also contrib- 
ute to thrombosisJ 7 Localised hypoxia in the leg could 
result in systemic damage when activated white blood 
cells or their products damage the endothelium in 
sites distant from the affected limb. 
The aim of this study was to test the hypothesis that 
high levels of polymorphonuclear leukocyte lastase 
known to be present in patients with peripheral 
atherosclerosis 14 would be associated with the evi- 
dence of damage to the endothelium (as measured by 
plasma levels of von Willebrand factor and soluble 
thrombomodulin 1°'11) and tissue hypoxia (as 
measured by a transcutaneous oxygen probe). Our 
source material of patients with peripheral occlusive 
arterial disease was controlled by age and sex 
matched subjects who were asymptomatic for 
atherosclerosis. 
Subjects and Methods 
Subjects 
The cases were twenty two patients (18 men, mean age 
58 years, range 44-75, 8 current smokers) with 
atherosclerosis of the iliac, femoral or popliteal arteries 
as defined by Doppler/high resolution B mode ultra- 
sound imaging and a reduction in the ankle to brachial 
blood pressure index to less than 0.8. The patients 
were free of disease usually associated with elevated 
elastase, soluble thrombomodulin or von Willebrand 
factor (acute phase response, diabetes, cancer, hyper- 
thyroidism, nephropathy (creatine > 115 ~mol/1) and 
hepatopathy (ASAT, ALAT > 40 IU/ml)). Presence of 
asymptomatic disease at other loci (carotids, coronary 
circulation) cannot be excluded : the presenting 
symptom was intermittent claudication. We also 
recruited an equal number of age (mean 56 years, 
range 46-80) and sex (18 men) matched asymptornatic 
controls from healthy hospital and laboratory staff, 
and from patients attending hospital for endoscopy or 
for hernia repair. There were five current smokers in 
this group. Transcutaneous oxygen (TcPO2) was meas- 
ured (Radiometer Copenhagen) in all subjects whilst 
lying in the supine rest position on the same day as 
blood sampling. The probe was sited at the dorsum of 
the foot, between the first and the second cuneiform 
bones (territory of the arcuate artery and the dorsal 
metatarsal rteries). 
Methods 
von Willebrand factor was measured by a standard 
ELISA technique using commercial antisera (Dako- 
Patts, High Wycombe, U.K.) as fully described else- 
whereY Soluble thrombomodulin was measured 
using a commercial ELISA kit (Diagnostica Stago, 
Gennevilliers, Paris, France). 6 Plasma elastase was 
measured by an ELISA using sheep anti-human 
elastase and peroxidase-conjugated sheep anti-human 
antitrypsin from The Binding Site, Birmingham, U.K. 
and a polymorphonuclear leukocyte elastase cali- 
brator from Merck Ltd, U.K. 19 The intra-assay repro- 
ducibility of laboratory methods were < 5%, inter- 
assay variance was < 10%. 
Statistics 
With our previous experience in measurement of von 
Willebrand factor and soluble thrombomodulin, 1°'11 
we took an increase in either index of 30% to be 
clinically significant. Thus for a power of 90% we 
required 40 subjects. 2° Comparing patients with con- 
trols, data distributed normally (percutaneous oxygen, 
von Willebrand factor and soluble thrombomodulin) 
was analysed by t-testing. Elastase data was distrib- 
uted non-normally was analysed by the Mann-Whit- 
ney U-test. In view of multiple testing we took 
p < 0.0125 to be significant (Bonferroni's correction). 
Data from the patients group was correlated by 
Spearman's non-parametric rank method. A stepwise 
multiple regression analysis was performed which 
entered each one of the four indices as dependent 
variables in turn against he other three as independ- 
ent variables. All analyses were performed on a 
Minitab 8 extended package. 
Results 
Differences between the patients and the controls is 
shown in Table 1. There were contrasts in levels of von 
Willebrand factor, soluble thrombomodulin and poly- 
morphonuclear leukocyte elastase (which were all 
increased) whilst levels of percutaneous oxygen were 
lower in the patients. Table 2 shows the Spearman's 
correlations and corresponding univariate p-values. 
There were significant inverse correlates between von 
Willebrand factor and percutaneous oxygen (Fig. 1) 
and between soluble thrombomodulin and percuta- 
neous oxygen (Fig. 2). Elastase correlated with soluble 
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Table 1. Differences in percutaneous oxygen, von Wil lebrand 
factor, soluble thrombomodul in and elastase between patients and 
controls 
Patients Controls p 
Percutaneous oxygen (mmHg) 32±13 69±17 
vonW~fllebrandfactor ~U/dl) 117±60 107±36 
Soluble Thrombomodulin 
(ng/rnl) 76.5±29.8 54±13 
Elastase (ng/ml) 46 19 
(17-133) (8-47) 
<0.001 
<0.0001 
<0.001 
<0.001 
Data are mean + S.D. or median and range analysed by t-test or 
Mann-Whitney respectiveI:~ 
Table 2. Spearman correlations and univariate probabil ity values 
between percutaneous oxygen, (pO2), von WiUebrand factor (vWf), 
soluble thrombomodul in (sTM) and elastase 
p• z vWf sTM 
vWf r= -0.60 
p=0.004 
sTM r= -0.53 r=0.46 
p=0.011 p=0.029 
Elastase r= -0.35 r=0.27 
p=0.121 p=0.228 
r=0.48 
p=0.023 
thrombomodulin (Fig. 3) and there was a weak 
correlation between von Willebrand factor and soluble 
thrombomodulin. In a multiple regression analysis set 
to detect a significance at p < 0.05, von Willebrand 
factor selected percutaneous oxygen and then soluble 
thrombomodulin; soluble thrombomodul in first 
selected percutaneous oxygen, then elastase and 
finally von Willebrand factor; percutaneous oxygen 
selected von Willebrand factor followed by soluble 
thrombomodulin; and elastase selected only soluble 
thrombomodulin. 
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Fig. 1. Inverse relationship between percutaneous oxygen and 
soluble thrombomodulin. 
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Fig. 2. Inverse relationship between percutaneous oxygen and yon 
WiUebrand factor. 
Discuss ion  
Endothelial cell damage, tissue hypoxia and the 
activation of polymorphonuclear leukocytes have all 
been reported in atherosclerosis. 9-14'z1'22 Previous 
studies have, however, failed to assess the relation- 
ships between the above indices, and use them 
together to suggest a mechanism for the disease 
process. We have addressed this issue by measuring 
these indices concurrently within one group of 
patients. Our results reveal a significant group of 
associations between endothelial cell injur~ neu- 
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Fig. 3. Relationship between soluble thrombomodulin and 
elastase. 
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trophil elastase and hypoxia which may be important 
for the understanding of any systemic damage caused 
by limb ischaemia. 
Endothelial cell injury in the patients is evident. The 
possible mechanisms for this damage include the 
cytotoxic activity of elastase (known to be increased in 
patients with peripheral arterial disease ~4) derived 
from trapped, activated polymorphonuclear leuko- 
cytes and the correlation between elastase and soluble 
thrombomodulin, although weak, supports this asser- 
tion. Notably the correlation coefficient between per- 
cutaneous oxygen and elastase is respectable and 
would be likely to produce significance with larger 
numbers of patients. A large epidemiology study has 
reported a correlation between von Willebrand factor 
and leukocyte count 21 and we have noted an increase 
in von Willebrand factor following a neutrophil 
leukocytosis n patients with intermittent claudication 
undergoing treadmill exercise. 22Elastase will induce 
the release of von Willebrand factor and soluble 
thrombomodulin from endothelial cells in vitro, ~2"23 
and will increase the permeability of cultured pulmo- 
nary endothelial cell monolayers. 24 Greer et aI. 2s have 
reported a positive correlation between von Will- 
ebrand factor and elastase in a study of pre-eclampsia, 
although in our study the relationship between these 
molecules failed to reach statistical significance, prob- 
ably because of the small number of patients we 
studied. 
Increased levels of the endothelial cell products in 
the plasma may have consequences forhaemostasis a
increased von Willebrand factor is procoagulant (sup- 
porting the activity of factor VIII and with the 
potential to mediate platelet adhesion to the sub- 
10 endothelium ). Increased soluble thrombomodulin 
reflects cleavage of cell surface thrombomodulin, thus 
leading to a procoagulant state as the membrane 
bound form is a cofactor for activated protein C and 
the soluble form is unlikely to contribute significantly 
to haemostasis. 26 The weak correlation between the 
two endothelial cell products, von Willebrand factor 
and soluble thrombomodulin, suggests different solu- 
blisation mechanisms. This is not surprising as von 
Willebrand factor is stored preformed in intracellular 
Weibel-Palade bodies and actively secreted by endo- 
thelial cells ~° whilst thrombomodulin is normally only 
expressed at the cell membrane and the soluble form 
results from deavage of the membrane form by 
proteases uch as neutrophil elastase. 26 A further 
possible reason for the poor correlation is that von 
Willebrand factor is influenced by inflammatory c to- 
kines such as interleukin-1 m likely to be present in our 
patients whilst soluble thrombomodulin is not. 27 
Hence increased von Willebrand factor may represent 
some degree of dysfunction due to endothelial cell 
activation in addition to damage while soluble throm- 
bomodulin may mark only damage. 2sAlternatively a 
poor correlation may result from release by different 
endothelial cell vascular beds (e.g. lung, leg) in 
different patients. Thus von Willebrand factor and 
soluble thrombomodulin provide complimentary rep- 
resentations of endothelial cell insult. 
The additional burden of morbidity and mortality in 
patients with peripheral atherosderosis may be 
explained by the increased levels of neutrophil elas- 
tase, von Willebrand factor and soluble thrombomo- 
dulin in these patients. The correlation between the 
degree of lower limb hypoxia and the markers of 
endothelial cell damage suggests the two are related. 
Furthermore, the correlation between eutrophil elas- 
tase and endothelial cell damage suggests that the 
latter may be caused by the release of cytotoxic 
enzymes from activated neutrophils. Our data contrib- 
utes to the hypothesis that the endothelium and 
neutrophil are of prime importance in 
atherosclerosis.3"9"29 
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